利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

108 条记录 (耗时 0.065 秒)

    Methods, Systems, and Devices for Analyzing Patient Data
    72.
    发明申请
    Methods, Systems, and Devices for Analyzing Patient Data 审中-公开
    用于分析患者数据的方法，系统和设备

    公开(公告)号：US20110245634A1

    公开(公告)日：2011-10-06

    申请号：US13078711

    申请日：2011-04-01

    申请人： Pinaki Ray ,  David Price

    发明人： Pinaki Ray ,  David Price

    IPC分类号： A61B5/145

    CPC分类号： A61B5/14532 ,  A61B5/0002 ,  A61B5/1486 ,  A61B5/7275 ,  G01N33/48792 ,  G16H50/20 ,  G16H50/30 ,  G16H50/50

    摘要： Described herein is a method of analyzing an analyte distribution from discrete, quasi-continuous or continuous measurements to determine a glycemic state of a patient in order to understand how often, and for how long, a patient's post-prandial glucose is out of control without requiring laboratory blood test and especially post-prandial levels laboratory analysis. The systems, devices, and methods assist in predicting risk levels of developing diabetes-associated complications. Therefore applicants have recognized also a need for a tool which facilitates stratification of patients for risk of and/or onset of one or more complications having the same HbA1c level.

    摘要翻译： 本文描述的是从离散的，准连续的或连续的测量中分析分析物分布的方法，以确定患者的血糖状态，以便了解患者的餐后葡萄糖的频率以及多长时间，失去控制，没有 需要实验室血液检查，特别是餐后水平的实验室分析。 系统，装置和方法有助于预测发展为糖尿病相关并发症的风险水平。 因此，申请人也认识到需要一种能够使患者具有相同HbA1c水平的一种或多种并发症的风险和/或发作的分层的工具。

    INHALABLE PHARMACEUTICAL COMPOSITION
    73.
    发明申请
    INHALABLE PHARMACEUTICAL COMPOSITION 审中-公开
    不可食用的药物组合物

    公开(公告)号：US20110212137A1

    公开(公告)日：2011-09-01

    申请号：US13027371

    申请日：2011-02-15

    申请人： Paul Michael Dorinsky ,  David Price

    发明人： Paul Michael Dorinsky ,  David Price

    IPC分类号： A61K9/12 ,  A61K31/573 ,  A61P11/06

    CPC分类号： A61K31/57 ,  A61K9/008

    摘要： An inhalable pharmaceutical solution aerosol comprising beclometasone dipropionate, ethanol and a propellant selected from 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof, wherein the aerosol has a droplet size having a mass median aerodynamic diameter of 0.5-2.0 μm, for maintaining lung function above 60% of baseline FEV1, or reducing the occurrences of lung function falling below 60% of baseline FEV1.

    摘要翻译： 一种可吸入的药物溶液气溶胶，其包含二丙酸倍氯米松，乙醇和选自1,1,1,2-四氟乙烷，1,1,1,2,3,3,3-七氟丙烷及其混合物的推进剂，其中气溶胶具有 液滴尺寸具有0.5-2.0μm的质量中值空气动力学直径，用于将肺功能保持在基线FEV1的60％以上，或减少低于基线FEV1的60％的肺功能发生。

    PET HARNESS SAFETY SYSTEM
    76.
    发明申请
    PET HARNESS SAFETY SYSTEM 审中-公开
    PET线束安全系统

    公开(公告)号：US20110067648A1

    公开(公告)日：2011-03-24

    申请号：US12885700

    申请日：2010-09-20

    申请人： Tibor Siklosi ,  David Price

    发明人： Tibor Siklosi ,  David Price

    IPC分类号： A01K27/00

    CPC分类号： A01K27/002

    摘要： A pet harness safety system has a harness assembly with two parallel body loops and a carabiner tether assembly with opposing carabiners. During usage, one of the carabiners is secured to a reinforced loop on each of the body loops of the harness assembly and the other carabiner is secured to an in-vehicle restraint system. The body loops are substantially parallel to the body of the dog such that only its shoulders are encircled by the body loops, and are adjustably joined together to form a completed or closed system.

    摘要翻译： 宠物线束安全系统具有带有两个平行的主体环的线束组件和具有相对的卡扣机的骑手系绳组件。 在使用期间，其中一个固定器被固定在线束组件的每个主体环上的加强环上，另一个卡扣固定到车内约束系统。 身体环基本上平行于狗的身体，使得只有其肩部被身体环环绕，并且可调节地结合在一起以形成完整或封闭的系统。

    Analyte Measurement and Management Device and Associated Methods
    77.
    发明申请
    Analyte Measurement and Management Device and Associated Methods 审中-公开
    分析物测量和管理装置及相关方法

    公开(公告)号：US20100256047A1

    公开(公告)日：2010-10-07

    申请号：US12417875

    申请日：2009-04-03

    申请人： Zara Sieh ,  David Horwitz ,  David Price ,  Peter Krulevitch ,  Donna Savage ,  Robert Shartle

    发明人： Zara Sieh ,  David Horwitz ,  David Price ,  Peter Krulevitch ,  Donna Savage ,  Robert Shartle

    IPC分类号： A61K38/28 ,  A61P3/10 ,  G06F19/00

    CPC分类号： G06F19/3456

    摘要： A method for measuring and managing an analyte (e.g., blood glucose) in a bodily fluid includes storing a therapeutic administration protocol in a memory module of an analyte measurement and management device and measuring the analyte in the bodily fluid sample using an analyte measurement module of the device. The method also includes calculating, with a processor module of the device, a recommended therapeutic agent dosage (for example, an insulin dosage) and a recommended administration time for user-activated delivery of the dosage by employing the therapeutic administration protocol. The method further includes displaying the recommended therapeutic agent dosage and administration time to a user on a visual display of the device, delivering a therapeutic agent dosage to the user via a user-activated therapeutic agent delivery device, and detecting the user-activated administration of the therapeutic agent using a delivery device communication module of the device. In addition, the method includes communicating the aforementioned detection to the processor module and/or memory module using the delivery device communication module. The method employs analyte measurement, memory, processor, and delivery device modules, as well as a visual display, and user interface that are integrated as a single hand-held unit.

    摘要翻译： 用于测量和管理体液中的分析物（例如，血糖）的方法包括将分析物测量和管理装置的存储器模块中的治疗性给药方案存储在体液样品中，并使用分析物测量模块 装置。 该方法还包括利用该设备的处理器模块，通过使用治疗性给药方案来计算推荐的治疗剂剂量（例如，胰岛素剂量）和用户激活的剂量递送的推荐给药时间。 该方法还包括在设备的视觉显示上向用户显示推荐的治疗剂剂量和给药时间，经由用户激活的治疗剂递送装置向用户递送治疗剂剂量，以及检测用户激活的给药时间 所述治疗剂使用所述装置的递送装置通信模块。 此外，该方法包括使用传送设备通信模块将上述检测传送到处理器模块和/或存储器模块。 该方法采用分析物测量，存储器，处理器和传送设备模块，以及作为单个手持单元集成的可视显示器和用户界面。

    ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS
    78.
    发明申请
    ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS 审中-公开
    分析测量和管理设备及相关方法

    公开(公告)号：US20100016700A1

    公开(公告)日：2010-01-21

    申请号：US12505007

    申请日：2009-07-17

    申请人： Zara Sieh ,  David Horwitz ,  David Price ,  Peter Krulevitch ,  Donna Savage ,  Robert Shartle

    发明人： Zara Sieh ,  David Horwitz ,  David Price ,  Peter Krulevitch ,  Donna Savage ,  Robert Shartle

    IPC分类号： A61B5/00 ,  G06F3/048 ,  H04L9/32 ,  G08B1/08 ,  G06F15/16 ,  G06N5/02

    CPC分类号： A61B5/4839 ,  A61B5/14532 ,  G06F19/3418 ,  G06F19/3468 ,  G16H40/63

    摘要： Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.

    摘要翻译： 提供了糖尿病管理系统的各种实施例。 一个示例性系统可以包括分析物测量装置和治疗剂递送装置。 测量装置包括测量单元，显示器和第一无线模块。 治疗剂递送装置具有输送装置壳体，设置在壳体中的输送机构，其在用户或医疗保健提供者致动时将剂量的剂量递送给使用者，以及第二无线模块。 自动地，第二模块在不提示用户或用户的任何有效输入或动作的情况下，向第一无线模块发送指示：（a）递送的治疗剂的类型; 和（b）递送给使用者的治疗剂量; 或（c）施用治疗剂的治疗剂装置的类型。 还描述了糖尿病管理装置和方法。

    Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes
    79.
    发明申请
    Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes 审中-公开
    用于识别高血糖和低血糖模式的系统，方法和计算机程序代码，增加葡萄糖变异性和糖尿病无效自我监测

    公开(公告)号：US20080154513A1

    公开(公告)日：2008-06-26

    申请号：US11943226

    申请日：2007-11-20

    申请人： Boris P. Kovatchev ,  David Price ,  Erik Otto ,  Alan Coulson

    发明人： Boris P. Kovatchev ,  David Price ,  Erik Otto ,  Alan Coulson

    IPC分类号： G06F17/18 ,  G01N33/48

    CPC分类号： G06F19/3456 ,  G16H15/00 ,  G16H50/20

    摘要： A method, system, and computer program product related to the maintenance of optimal control of diabetes, and is directed to predicting patterns of hypoglycemia, hyperglycemia, increased glucose variability, and insufficient or excessive testing for the upcoming period of time, based on blood glucose readings collected by a self-monitoring blood glucose device. The method, system, and computer program product pertain directly to the enhancement of existing home blood glucose monitoring devices, by introducing an intelligent data interpretation component capable of predicting and alerting the user to periods of increased risk for hyperglycemia, hypoglycemia, increased glucose variability, and ineffective testing, and to the enhancement of emerging self-monitoring blood glucose devices by the same features. With these predictions the diabetic can take steps to prevent the adverse consequences associated with hyperglycemia, hypoglycemia, and increased glucose variability.

    摘要翻译： 与维持糖尿病最佳控制相关的方法，系统和计算机程序产品，旨在预测低血糖，高血糖，葡萄糖变异性增加，以及基于血糖的即将到来时间的不足或过量测试 通过自我监测血糖仪收集的数据。 该方法，系统和计算机程序产品直接关系到现有家用血糖监测装置的增强，引入了智能数据解释组件，能够将用户预测和警告高血糖，低血糖，增加的葡萄糖变异性风险增加的时期， 和无效的测试，以及通过相同的特征增强新兴的自我监测血糖仪。 通过这些预测，糖尿病患者可以采取措施来预防与高血糖，低血糖和葡萄糖变异性增加相关的不良后果。

    Sulfonamide derivatives
    80.
    发明申请
    Sulfonamide derivatives 审中-公开
    磺酰胺衍生物

    公开(公告)号：US20080090873A1

    公开(公告)日：2008-04-17

    申请号：US11906796

    申请日：2007-10-02

    申请人： Lyn Jones ,  Graham Lunn ,  David Price

    发明人： Lyn Jones ,  Graham Lunn ,  David Price

    IPC分类号： A61K31/4465 ,  A61P11/00 ,  C07D211/46

    CPC分类号： C07D211/46

    摘要： The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

    摘要翻译： 本发明涉及式（1）化合物以及制备用于制备含这些衍生物的组合物和用途的中间体的方法。 根据本发明的化合物可用于许多疾病，病症和病症，特别是炎性，过敏性和呼吸道疾病，病症和病症。